Myriad Genetics Financials

Values in thousands	2026-09-30	2026-06-30	2026-03-31	2025-12-31
Revenue	$202,700	$190,700	$200,400	$209,800
Gross Profit	137,700	127,000	137,600	146,800
EBITDA	-39,900	-26,000	-17,500	8,100
EBIT		-38,500	-30,000	-4,500
Net Income	-43,900	-43,200	-34,100	-7,900
Net Change In Cash	202,700	190,700	200,400	209,800
Free Cash Flow	-6,500	-10,400	-21,100	4,600
Cash	107,100	115,200	124,400	149,600
Basic Shares	95,700	94,800	93,700	93,300

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$824,500	$837,600	$753,200	$678,400
Gross Profit	576,600	585,400	517,000	476,400
EBITDA	-330,900	-59,500	-197,400	-84,700
EBIT	-384,600	-120,700	-259,300	-137,400
Net Income	-365,900	-127,300	-263,300	-112,000
Net Change In Cash	824,500	837,600	753,200	678,400
Free Cash Flow	-25,600	-38,400	-184,200	-151,600
Cash	149,600	102,400	132,100	56,900
Basic Shares	93,300	90,600	82,800	80,600